Unfortunately, we don't support Internet Explorer anymore as it has been replaced by Microsoft Edge. Please try using Edge or an alternative modern browser for the best experience.
Leslie Williams is a founder, CEO, and board director with more than 25 years of experience building and leading high-growth life science companies, including HC Bioscience, ImmusanT, Ventaira Pharmaceuticals, and INO Therapeutics. She is currently President & CEO of DaCapo Brainscience, where she is advancing novel small-molecule therapeutics for neurodegenerative diseases, beginning with Parkinson’s disease. Across her career, Leslie has founded and scaled innovative biotech ventures spanning genetic medicine, immunology, oncology, and critical care — raising more than $300 million in venture and non-dilutive capital and leading organizations from discovery through clinical development She was a venture partner at Battelle Ventures and started her industry career at Merck and GSK. A former critical-care nurse at Duke University, Leslie brings a deeply patient-centered lens to leadership. She serves on multiple industry and nonprofit boards and is passionate about building mission-driven companies that translate bold science into meaningful impact for patients.
